Cannabis M&A Spree Continues with Supreme’s Merger with Blissco


Ash Stringer

August 2nd, 2019

App, Exclusive, News, Top News


The cannabis industry is quickly moving through a well-known cycle for emerging markets. Like Google in the tech industry, early market entrants that have become successful in a given subset of the fragmented market are starting to look to mergers and acquisitions to expand their geographic and product footprint. The result is often a mature industry with two or three companies capturing 70 to 90 percent of the market share.

The most famous example is Canopy Growth Corp.’s (NYSE: CGC) (TSX: WEED) $3.4 billion deal with Acreage Holdings Inc. (CSE: ACRG.U). In exchange for a $300 million upfront commitment, Canopy Growth bought the right to acquire the U.S. market leader when cannabis legalization occurs on a federal level. The combined company could become an overnight leading producer across all of North America.

Let’s take a look at how The Supreme Cannabis Co.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recent merger with Blissco fits into this same model and what investors can look forward to next.

Expanding into Wellness

Supreme Cannabis’ merger with Blissco was more than a move to increase its revenue and market capitalization—it was a strategic acquisition that accelerates its entry into the lucrative wellness subset of the market with an established brand. Founded in 2013, Blissco has become Canada’s leading cannabis wellness brand with a 12,000 sq. ft., state-of-the-art extraction, processing and cultivation facility located in Vancouver.

Prior to the merger, Blissco was awarded a comprehensive sales license from Health Canada to sell bulk cannabis and pre-packaged, labeled and tested cannabis products to medical patients and provinces. The company had signed supply agreements with British Columbia, Saskatchewan, New Brunswick, and Alberta, as well as Pharmadrug in Germany. It also submitted a license amendment to Health Canada to allow the sale of oil.

Blissco’s focus on ultra-premium cannabis products is well-aligned with Supreme’s similar focus on high-quality flower and pre-rolls, but unlike Supreme, it has been extracting cannabis oil since August of 2018. With its EU GMP-compliant facility, Supreme can immediately leverage its high-quality flower inputs to create near-term, large-scale extraction operations capable of serving multiple brands under its growing umbrella.

Focusing on Growth Ahead

Supreme Cannabis plans to acquire Truverra, a global medical cannabis brand, to further expand its footprint in the wellness space. Located in the Netherlands, Truverra sells a broad portfolio of hemp-based CBD products across select European markets. These products contain a carefully measured quantity of clean and pure CBD oil drawn from whole plant hemp extract that meets European standards.

In order to support this next phase of growth, the company appointed Ash Rajendra as Chief Information Officer and Valerie Rother as vice president of human capital and talent development. Both of these individuals bring a wealth of experience and knowledge necessary to help the company manage these two key acquisitions, as well as pave the way for growth in the nascent cannabis industry.

The company also continues to adopt governance best practices at the board level. Mr. John Fowler resigned from the Board of Directors in order to make room for more independent directors. Mr. Fowler will continue to serve as Chief Advocacy Officer & Managing Director of Flower and Concentrates while the board begins a search for a new independent board member that will bring diverse background, experience and operating knowledge.

Looking Ahead

Supreme Cannabis Co.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) acquisition of two wellness brands marks a move to stake out a key subset of the industry. In addition to adding scale to its operations, the acquisitions provide valuable new brands and extraction capabilities that could help drive long-term shareholder value. Investors interested in the wellness side of the industry may want to take a closer look at the company following these catalysts.

For more information, visit the company’s website at www.supreme.ca.

The above article is sponsored content.

Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Avatar

About Ash Stringer



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading